Global Direct-to-consumer Genetic Testing Market was valued at USD XX Billion in the year 2021. Global Direct-to-consumer Genetic Testing Market is further estimated to grow at a CAGR of XX% from 2022 to 2030 it will reach USD XX Billion by the year 2030. The North America region holds the highest market share in 2021 and the Asia Pacific is considered as the fastest growing market in the forecasted period. At a country level, US, China are projected to grow strongly in the coming years due to increasing density of population and funding through Research and Development.
The Global Direct-to-consumer Genetic Testing Report 2022-2030 covers market opportunities and challenges, key market regulations’ information, analysis of new products from the market players and key market trends, market share analysis for key players, supply chain and value chain analysis, product and Material trends, pricing analysis, emerging applications, technologies and major recent developments. This information has also been provided for the major country markets in these regions. Market shares, size and growth potential are assessed for these major country markets. Market opportunities, challenges, government regulations, market share analysis by major competitors, recent major market developments (product launches, M&A, partnerships, etc.) and other information have been covered for the major country markets listed in this section.
On the basis of Type, the market is divided as Ancestry & Relationship Testing, Nutrigenomics Testing, Predictive Testing, Carrier Testing, Other Test Types. In which Ancestry & Relationship Testing for the largest market share due to increasing demand in future market trends. Regional breakdown and deep analysis of each of the aforesaid segments is included for North America, Europe, Asia-Pacific, and ROW.
Market player analysis of major companies such as 23andMe, Inc.; Ancestry.com, LLC; Any Lab Test Now; Color Genomics, Inc.; Direct Laboratory Services, LLC; Easy DNA; Full Genomes Corporation, Inc.; Gene by Gene, Ltd.; Genesis Healthcare; Helix OpCo LLC; Request A Test, Ltd.; Sonora Quest Laboratories LLC; Xcode Life Sciences and Others..

1 INTRODUCTION
1.1 OBJECTIVES
1.2 RESEARCH METHODOLOGY
1.2.1 SECONDARY DATA
1.2.2 PRIMARY DATA
1.2.3 MARKET SIZE ESTIMATION
1.2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
1.3 STAKEHOLDERS
1.4 RESEARCH ASSUMPTIONS
1.5 LIMITATION
2 EXECUTIVE SUMMARY
3 MARKET OUTLOOK
3.1 INTRODUCTION
3.2 OPPORTUNITIES MATRIX
3.3 MARKET CHALLENGES
3.4 MARKET SHARE ANALYSIS
3.5 VALUE CHAIN ANALYSIS
3.6 DEMAND SIDE ANALYSIS
3.7 SUPPLY SIDE ANALYSIS
3.8 PORTER’S FIVE FORCES MODEL
3.8.1 DEGREE OF COMPETITION
3.8.2 BARGAINING POWER OF BUYERS
3.8.3 BARGAINING POWER OF SUPPLIERS
3.8.4 THREAT FROM SUBSTITUTES
3.8.5 THREAT FROM NEW ENTRANTS
4 INDUSTRY TRENDS
4.1 PRODUCT LIFE CYCLE
4.2 NEW MARKET ENTRY STRATEGY
4.3 PESTEL ANALYSIS
4.4 PRICING ANALYSIS
4.5 TRADE DATA
4.6 TECHNOLOGICAL OVERVIEW
4.7 FUTURE OUTLOOK MARKET TRENDS
4.8 MACRO-ECONOMIC VARIABLES (DEPENDENT AND INDEPENDENT VARIABLES)
4.9 MULTIFACTOR BASED SENSITIVITY ANALYSIS
4.10 REGRESSION MATRIX
4.11 COVID-19 IMPACT ANALYSES
4.12 GE MATRIX
5 DIRECT-TO-CONSUMER GENETIC TESTING TYPE ANALYSIS
5.1 INTRODUCTION
5.2 HISTORICAL MARKET TYPE ANALYSIS, 2016-2020
5.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
5.4 Y-O-Y GROWTH TREND ANALYSIS
5.5 CARRIER SCREENING TEST
5.6 GENETIC HEALTH RISK (GHR) TESTS
5.7 PHARMACOGENETICS TESTS
5.8 CANCER PREDISPOSITION TESTS
5.9 LOW RISK GENERAL WELLNESS TESTS
5.10 ANCESTRY TESTS
5.11 PATERNITY TESTING
5.12 CANCER SUSCEPTIBILITY TESTS
6 DIRECT-TO-CONSUMER GENETIC TESTING TECHNOLOGY TYPE ANALYSIS
6.1 INTRODUCTION
6.2 HISTORICAL MARKET TECHNOLOGY TYPE ANALYSIS, 2016-2020
6.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
6.4 Y-O-Y GROWTH TREND ANALYSIS
6.5 SNP-CHIP GENOTYPING
6.6 WHOLE GENOME SEQUENCING
6.7 NEXT GENERATION SEQUENCING
6.8 SANGER SEQUENCING
7 DIRECT-TO-CONSUMER GENETIC TESTING SAMPLE TYPE ANALYSIS
7.1 INTRODUCTION
7.2 HISTORICAL MARKET SAMPLE TYPE ANALYSIS, 2016-2020
7.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
7.4 Y-O-Y GROWTH TREND ANALYSIS
7.5 SALIVA SAMPLE
7.6 BLOOD SAMPLE
8 DIRECT-TO-CONSUMER GENETIC TESTING DISTRIBUTION CHANNEL ANALYSIS
8.1 INTRODUCTION
8.2 HISTORICAL MARKET DISTRIBUTION CHANNEL ANALYSIS, 2016-2020
8.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
8.4 Y-O-Y GROWTH TREND ANALYSIS
8.5 ONLINE
8.6 OVER-THE-COUNTER
9 DIRECT-TO-CONSUMER GENETIC TESTING MARKET APPLICATION ANALYSIS
9.1 INTRODUCTION
9.2 HISTORICAL MARKET APPLICATION ANALYSIS, 2016-2020
9.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
9.4 Y-O-Y GROWTH TREND ANALYSIS
9.5 CANCER DIAGNOSIS
9.6 CARDIOVASCULAR DISEASE DIAGNOSIS
9.7 GENETIC DISEASE DIAGNOSIS
10 GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING REGIONAL ANALYSIS
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 NORTH AMERICA HISTORICAL MARKET COUNTRY ANALYSIS, 2016-2020
10.2.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
10.2.3 Y-O-Y GROWTH TREND ANALYSIS
10.2.3.1 U.S.
10.2.3.2 Canada
10.2.3.3 Mexico
10.3 ASIA-PACIFIC
10.3.1 APAC HISTORICAL MARKET COUNTRY ANALYSIS, 2016-2020
10.3.2 Y-O-Y GROWTH TREND ANALYSIS
10.3.2.1 China
10.3.2.2 Japan
10.3.2.3 Korea
10.3.2.4 India
10.3.2.5 Southeast Asia
10.4 MIDDLE EAST AND AFRICA
10.4.1 MIDDLE EAST AND AFRICA HISTORICAL MARKET COUNTRY ANALYSIS, 2016-2020
10.4.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
10.4.3 Y-O-Y GROWTH TREND ANALYSIS
10.4.3.1 Saudi Arabia
10.4.3.2 UAE
10.4.3.3 Egypt
10.4.3.4 Nigeria
10.4.3.5 South Africa
10.5 EUROPE
10.5.1 EUROPE HISTORICAL MARKET COUNTRY ANALYSIS, 2016-2020
10.5.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
10.5.3 Y-O-Y GROWTH TREND ANALYSIS
10.5.3.1 Germany
10.5.3.2 France
10.5.3.3 UK
10.5.3.4 Russia
10.5.3.5 Italy
10.6 LATIN AMERICA
10.6.1 LATIN AMERICA HISTORICAL MARKET COUNTRY ANALYSIS, 2016-2020
10.6.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
10.6.3 Y-O-Y GROWTH TREND ANALYSIS
10.6.3.1 Brazil
10.6.3.2 Argentina
10.6.3.3 Columbia
11 MARKET PLAYERS
11.1 23ANDME, INC.
11.1.1 BUSINESS OVERVIEW:
11.1.2 PRODUCT PORTFOLIO
11.1.3 RECENT DEVELOPMENTS
11.1.4 SWOT ANALYSIS:
11.2 ANCESTRY.COM, LLC
11.3 ANY LAB TEST NOW
11.4 COLOR HEALTH, INC.
11.5 DIRECT LABORATORY SERVICES, LLC
11.6 DNA DIAGNOSTICS CENTER
11.7 EASY DNA
11.8 FULL GENOMES CORPORATION, INC.
11.9 GENE BY GENE, LTD.
11.10 GENESIS HEALTHCARE
11.11 HELIX OPCO LLC
11.12 LABORATORY CORPORATION OF AMERICA® HOLDINGS
11.13 LIVING DNA
11.14 MAPMYGENOME INDIA LIMITED
11.15 MYHERITAGE
11.16 OMECARE
11.17 POSITIVE BIOSCIENCE, INC.
11.18 QUEST DIAGNOSTICS, INC.
11.19 REQUEST A TEST, LTD.
11.20 SONORA QUEST LABORATORIES LLC
11.21 XCODE LIFE SCIENCES
11.22 SHUWEN HEALTH SCIENCES
11.23 CANADIAN DNA SERVICES
11.24 DNA SERVICES OF AMERICA
11.25 SURE GENOMICS
11.26 WALK-IN-LAB
11.27 ALPHA BIOLABORATORIES
11.28 KAILOS GENETICS
11.29 GENOMICS EXPRESS
11.30 DNA4LIFE
12 ABOUT US

TABLE 1 DIRECT-TO-CONSUMER GENETIC TESTING REGIONAL ANALYSIS, 2021–2030 (USD MILLION)
TABLE 2 GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET, 2021–2030, (USD MILLION)
TABLE 3 DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE REGIONAL ANALYSIS, 2021–2030 (USD MILLION)
TABLE 4 GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING HISTORICAL MARKET TYPE ANALYSIS, 2016-2020, (USD MILLION)
TABLE 5 DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 6 GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING HISTORICAL MARKET TECHNOLOGY TYPE ANALYSIS, 2016-2020, (USD MILLION)
TABLE 7 DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE TECHNOLOGY TYPE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 8 GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING HISTORICAL MARKET SAMPLE TYPE ANALYSIS, 2016-2020, (USD MILLION)
TABLE 9 DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE SAMPLE TYPE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 10 GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING HISTORICAL MARKET DISTRIBUTION CHANNEL ANALYSIS, 2016-2020, (USD MILLION)
TABLE 11 DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE DISTRIBUTION CHANNEL ANALYSIS, 2021–2030 (USD MILLION)
TABLE 12 GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING HISTORICAL MARKET APPLICATION ANALYSIS, 2016-2020, (USD MILLION)
TABLE 13 DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030 (USD MILLION)
TABLE 14 NORTH AMERICA DIRECT-TO-CONSUMER GENETIC TESTING HISTORICAL MARKET ANALYSIS, 2016-2020, (USD MILLION)
TABLE 15 NORTH AMERICA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 16 NORTH AMERICA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE TECHNOLOGY TYPE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 17 NORTH AMERICA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE SAMPLE TYPE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 18 NORTH AMERICA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE DISTRIBUTION CHANNEL ANALYSIS, 2021–2030 (USD MILLION)
TABLE 19 NORTH AMERICA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030 (USD MILLION)
TABLE 20 U.S. DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE TYPE ANALYSIS, 2016–2021
TABLE 21 U.S. DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 22 U.S. DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 23 CANADA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 24 CANADA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 25 MEXICO DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 26 MEXICO DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 27 APAC DIRECT-TO-CONSUMER GENETIC TESTING HISTORICAL MARKET ANALYSIS, 2016-2020, (USD MILLION)
TABLE 28 ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 29 ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE TECHNOLOGY TYPE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 30 ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE SAMPLE TYPE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 31 ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE DISTRIBUTION CHANNEL ANALYSIS, 2021–2030 (USD MILLION)
TABLE 32 ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030 (USD MILLION)
TABLE 33 CHINA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 34 CHINA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 35 JAPAN DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 36 JAPAN DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 37 KOREA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 38 KOREA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 39 INDIA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 40 INDIA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 41 SOUTHEAST ASIA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 42 SOUTHEAST ASIA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 43 MIDDLE EAST AND AFRICA DIRECT-TO-CONSUMER GENETIC TESTING HISTORICAL MARKET ANALYSIS, 2016-2020, (USD MILLION)
TABLE 44 MIDDLE EAST AND AFRICA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 45 MIDDLE EAST AND AFRICA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE TECHNOLOGY TYPE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 46 MIDDLE EAST AND AFRICA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE SAMPLE TYPE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 47 MIDDLE EAST AND AFRICA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE DISTRIBUTION CHANNEL ANALYSIS, 2021–2030 (USD MILLION)
TABLE 48 MIDDLE EAST AND AFRICA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030 (USD MILLION)
TABLE 49 SAUDI ARABIA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 50 SAUDI ARABIA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 51 UAE DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 52 UAE DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 53 EGYPT DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 54 EGYPT DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 55 NIGERIA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 56 NIGERIA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 57 SOUTH AFRICA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 58 SOUTH AFRICA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 59 EUROPE DIRECT-TO-CONSUMER GENETIC TESTING HISTORICAL MARKET ANALYSIS, 2016-2020, (USD MILLION)
TABLE 60 EUROPE DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 61 EUROPE DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE TECHNOLOGY TYPE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 62 EUROPE DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE SAMPLE TYPE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 63 EUROPE DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE DISTRIBUTION CHANNEL ANALYSIS, 2021–2030 (USD MILLION)
TABLE 64 EUROPE DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030 (USD MILLION)
TABLE 65 GERMANY DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 66 GERMANY DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 67 FRANCE DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 68 FRANCE DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 69 UK DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 70 UK DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 71 RUSSIA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 72 RUSSIA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 73 ITALY DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 74 ITALY DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 75 LATIN AMERICA DIRECT-TO-CONSUMER GENETIC TESTING HISTORICAL MARKET ANALYSIS, 2016-2020, (USD MILLION)
TABLE 76 LATIN AMERICA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 77 LATIN AMERICA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE TECHNOLOGY TYPE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 78 LATIN AMERICA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE SAMPLE TYPE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 79 LATIN AMERICA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE DISTRIBUTION CHANNEL ANALYSIS, 2021–2030 (USD MILLION)
TABLE 80 LATIN AMERICA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030 (USD MILLION)
TABLE 81 BRAZIL DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 82 BRAZIL DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 83 ARGENTINA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 84 ARGENTINA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 85 COLUMBIA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 86 COLUMBIA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 1 GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET, 2021–2030, (USD MILLION)
FIGURE 2 RESEARCH METHODOLOGY
FIGURE 3 GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE MARKET, 2021–2030, (USD MILLION)
FIGURE 4 GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE MARKET, 2021–2030, (USD MILLION)
FIGURE 5 MARKET OVERVIEW
FIGURE 6 SWOT ANALYSIS
FIGURE 7 MARKET SHARE ANALYSIS
FIGURE 8 SUPPLY CHAIN ANALYSIS
FIGURE 9 PORTER’S FIVE FORCES ANALYSIS
FIGURE 10 DIRECT-TO-CONSUMER GENETIC TESTING TYPE ANALYSIS
FIGURE 11 GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE MARKET TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 12 DIRECT-TO-CONSUMER GENETIC TESTING TECHNOLOGY TYPE ANALYSIS
FIGURE 13 GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE MARKET TECHNOLOGY TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 14 DIRECT-TO-CONSUMER GENETIC TESTING SAMPLE TYPE ANALYSIS
FIGURE 15 GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE MARKET SAMPLE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 16 DIRECT-TO-CONSUMER GENETIC TESTING DISTRIBUTION CHANNEL ANALYSIS
FIGURE 17 GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE MARKET DISTRIBUTION CHANNEL ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 18 DIRECT-TO-CONSUMER GENETIC TESTING APPLICATION ANALYSIS
FIGURE 19 GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE MARKET APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 20 GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE MARKET VOLUME SHARE REGIONAL ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 21 MARKET OVERVIEW, REGIONAL ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 22 MARKET SHARE BY COUNTRY
FIGURE 23 NORTH AMERICA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 24 NORTH AMERICA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE TECHNOLOGY TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 25 NORTH AMERICA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE SAMPLE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 26 NORTH AMERICA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE DISTRIBUTION CHANNEL ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 27 NORTH AMERICA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 28 U.S. DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 29 U.S. DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 30 CANADA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 31 CANADA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 32 MEXICO DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 33 MEXICO DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 34 MARKET SHARE BY COUNTRY
FIGURE 35 APAC DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 36 APAC DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE TECHNOLOGY TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 37 APAC DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE SAMPLE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 38 APAC DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE DISTRIBUTION CHANNEL ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 39 APAC DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 40 CHINA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 41 CHINA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 42 JAPAN DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 43 JAPAN DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 44 KOREA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 45 KOREA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 46 INDIA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 47 INDIA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 48 SOUTHEAST ASIA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 49 SOUTHEAST ASIA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 50 MARKET SHARE BY COUNTRY
FIGURE 51 MIDDLE EAST AND AFRICA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 52 MIDDLE EAST AND AFRICA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE TECHNOLOGY TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 53 MIDDLE EAST AND AFRICA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE SAMPLE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 54 MIDDLE EAST AND AFRICA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE DISTRIBUTION CHANNEL ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 55 MIDDLE EAST AND AFRICA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 56 SAUDI ARABIA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 57 SAUDI ARABIA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 58 UAE DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 59 UAE DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 60 EGYPT DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 61 EGYPT DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 62 NIGERIA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 63 NIGERIA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 64 SOUTH AFRICA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 65 SOUTH AFRICA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 66 MARKET SHARE BY COUNTRY
FIGURE 67 EUROPE DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 68 EUROPE DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE TECHNOLOGY TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 69 EUROPE DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE SAMPLE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 70 EUROPE DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE DISTRIBUTION CHANNEL ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 71 EUROPE DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 72 GERMANY DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 73 GERMANY DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 74 FRANCE DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 75 FRANCE DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 76 UK DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 77 UK DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 78 RUSSIA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 79 RUSSIA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 80 ITALY DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 81 ITALY DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 82 MARKET SHARE BY COUNTRY
FIGURE 83 LATIN AMERICA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 84 LATIN AMERICA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE TECHNOLOGY TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 85 LATIN AMERICA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE SAMPLE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 86 LATIN AMERICA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE DISTRIBUTION CHANNEL ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 87 LATIN AMERICA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 88 BRAZIL DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 89 BRAZIL DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 90 ARGENTINA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 91 ARGENTINA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 92 COLUMBIA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 93 COLUMBIA DIRECT-TO-CONSUMER GENETIC TESTING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 94 FINANCIAL OVERVIEW: